Synergy Pharmaceuticals (FRA:S90) EV-to-Revenue : 1.88 (As of Apr. 30, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Synergy Pharmaceuticals's enterprise value is €65.50 Mil. Synergy Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2018 was €34.91 Mil. Therefore, Synergy Pharmaceuticals's EV-to-Revenue for today is 1.88.

The historical rank and industry rank for Synergy Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

FRA:S90' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.8 Med: 16.5 Max: 415.1
Current: 1.83

During the past 12 years, the highest EV-to-Revenue of Synergy Pharmaceuticals was 415.10. The lowest was 1.80. And the median was 16.50.

FRA:S90's EV-to-Revenue is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.32 vs FRA:S90: 1.83

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-30), Synergy Pharmaceuticals's stock price is €0.00. Synergy Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 was €0.14. Therefore, Synergy Pharmaceuticals's PS Ratio for today is 0.00.

Synergy Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Synergy Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals EV-to-Revenue Chart

Synergy Pharmaceuticals Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

EV-to-Revenue

Get a 7-Day Free Trial

28.57

Synergy Pharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
EV-to-Revenue	Get a 7-Day Free Trial															77.89	28.57	16.97	13.79	11.93

Competitive Comparison of Synergy Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synergy Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's EV-to-Revenue falls into.

Synergy Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Synergy Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	65.504	/	34.912
	=	1.88

Synergy Pharmaceuticals's current Enterprise Value is €65.50 Mil.
Synergy Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was €34.91 Mil.

Synergy Pharmaceuticals (FRA:S90) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Synergy Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.00	/	0.142
	=	0.00

Synergy Pharmaceuticals's share price for today is €0.00.
Synergy Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.14.

Synergy Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Synergy Pharmaceuticals (FRA:S90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170

Website

http://www.synergypharma.com

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines